Disentangling tryptophan metabolism in inflammatory bowel diseases

Affiliations

¹ Department of Medicine 1, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Bayern, Germany.
² Internal Medicine I, Gastroenterology, Hepatology & Metabolism, Medizinische Universitat Innsbruck, Innsbruck, Austria timon-erik.adolph@i-med.ac.at.

Comment

Christoph Becker et al. Gut. 2023 Jul.

. 2023 Jul;72(7):1235-1236.

doi: 10.1136/gutjnl-2022-328853. Epub 2023 Jan 3.

¹ Department of Medicine 1, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Bayern, Germany.
² Internal Medicine I, Gastroenterology, Hepatology & Metabolism, Medizinische Universitat Innsbruck, Innsbruck, Austria timon-erik.adolph@i-med.ac.at.

No abstract available

Keywords: COLONIC MUCOSAL METABOLISM; GASTROINTESTINAL IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; Tryptophan.

Conflict of interest statement

Competing interests: None declared.

Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases.
Michaudel C, Danne C, Agus A, Magniez A, Aucouturier A, Spatz M, Lefevre A, Kirchgesner J, Rolhion N, Wang Y, Lavelle A, Galbert C, Da Costa G, Poirier M, Lapière A, Planchais J, Nádvorník P, Illes P, Oeuvray C, Creusot L, Michel ML, Benech N, Bourrier A, Nion-Larmurier I, Landman C, Richard ML, Emond P, Seksik P, Beaugerie L, Arguello RR, Moulin D, Mani S, Dvorák Z, Bermúdez-Humarán LG, Langella P, Sokol H. Michaudel C, et al. Gut. 2023 Jul;72(7):1296-1307. doi: 10.1136/gutjnl-2022-327337. Epub 2022 Oct 21. Gut. 2023. PMID: 36270778 Free PMC article.